<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04910841</url>
  </required_header>
  <id_info>
    <org_study_id>19-AOI-10</org_study_id>
    <nct_id>NCT04910841</nct_id>
  </id_info>
  <brief_title>Feasibility of Using the &quot;CGM GUARDIAN 2&quot; Interstitial Fluid Glucose Measurement System in Intensive Care Medicine</brief_title>
  <acronym>GALI</acronym>
  <official_title>Feasibility of Using the &quot;CGM GUARDIAN 2&quot; Interstitial Fluid Glucose Measurement System in Intensive Care Medicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glycemic imbalances are very common in shock patients admitted to intensive care units. A&#xD;
      blood glucose control every 2 hours is routinely performed in patients requiring insulin&#xD;
      therapy. In practice, we use a protocol and management software called &quot;CPG&quot; (Personalized&#xD;
      Control of Blood Glucose). This involves taking capillary samples from the fingertips. In&#xD;
      addition to the pain generated, local haematomas and sensitivity disorders have been&#xD;
      described. Night-time sampling also leads to repeated awakenings. The &quot;CGM GUARDIAN 2&quot; system&#xD;
      has been validated for the measurement of glucose in interstitial fluid in insulin-dependent&#xD;
      diabetic patients. An electrode is placed on the patient's abdomen or arm for up to 6 days.&#xD;
      This electrode consists of a needle that is inserted subcutaneously only during the&#xD;
      placement. The sugar level is read using a sensor placed on the electrode and an insulin pump&#xD;
      (which will not deliver therapy (for our study) and which will be used only as an information&#xD;
      reader to know the glucose level and trends). Interstitial fluid is automatically drawn from&#xD;
      the electrode every minute and averaged every 5 minutes.&#xD;
&#xD;
      This device has not yet been validated in resuscitation patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose level</measure>
    <time_frame>Day 6</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Hypotension</condition>
  <condition>Shock, Septic</condition>
  <arm_group>
    <arm_group_label>Connect</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CGM GUARDIAN 2</intervention_name>
    <description>continuous blood glucose monitoring system</description>
    <arm_group_label>Connect</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient in septic shock&#xD;
&#xD;
          -  Arterial hypotension requiring noradrenaline&#xD;
&#xD;
          -  Hyperglycaemia requiring insulin therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under guardianship, curatorship or deprived of liberty&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florent BILGER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florent BILGER</last_name>
    <phone>492035510</phone>
    <phone_ext>+33</phone_ext>
    <email>bilger.f@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Florent BILGER</last_name>
      <phone>492035510</phone>
      <phone_ext>+33</phone_ext>
      <email>bilger.f@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

